Valeric acid acts as a novel HDAC3 inhibitor against prostate cancer
Rui Han(Anhui Medical University), Lingeng Lu(Yale Cancer Center)
Cited by 30
Related Papers
Type I and II Endometrial Cancers: Have They Different Risk Factors?
|Journal of Clinical Oncology|2013|833
H19 lncRNA alters DNA methylation genome wide by regulating S-adenosylhomocysteine hydrolase
|Nature Communications|2015|271
RETRACTED ARTICLE: Tiliroside as a CAXII inhibitor suppresses liver cancer development and modulates E2Fs/Caspase-3 axis
|Scientific Reports|2021|42
CsNAC17 enhances resistance to <i>Colletotrichum gloeosporioides</i> by interacting with CsbHLH62 in <i>Camellia sinensis</i>
|Horticulture Research|2024|14
Antioxidant protein peroxiredoxin 6 suppresses the vascular inflammation, oxidative stress and endothelial dysfunction in angiotensin II-induced endotheliocyte
|General Physiology and Biophysics|2020|13